<Program>
Program
| September 15 (1st day) | |||
| Main Hall (Hitotsubasi Memorial Hall:2F) | Sub Hall (Conference Room1:2F) |
||
| 9:00 | Registration and information desk open | ||
| 9:30 | «Opening Remarks» President of The CBI society, Takatoshi Kawai (Eisai Co., Ltd.) Chair of CBI2010, Yoshiro Nakata (Gunma Univ.) |
||
| 10:00-12:00 «K:Keynote» Chair: Akihiko Konagaya (Tokyo Institute of Technology), Takatoshi Kawai (Eisai Co., Ltd.), Tadashi Horiuchi (Keio Univ.) |
|||
| 10:00-10:40 | K1: "Evolution of Computer Technology and its Impact on Science" Yoshio Oyanagi (Kogakuin Univ.) |
||
| 10:40-11:20 | K2: "In silico drug discovery for neglected diseases：
Shedding light in the darkness to bring hope into hopelessness" Noriaki Hirayama (Tokai Univ.) |
||
| 11:20-12:00 | K3: "Regenerative Medicine and Drug Development using iPS Cell
Technologies" Hideyuki Okano (Keio Univ.) |
||
| 14:00-16:00 «M1:Mini-Symposium» "Roles of Supercomputers in Drug Discovery and Development" Chair: Shigenori Tanaka (Kobe Univ.), Akihiko Konagaya (Tokyo Institute of Technology) |
14:00-16:00 «OA:Oral Session A» "Bioinformatics" Chair: Kenta nakai(The Institute of Medical Science, The University of Tokyo) |
||
| Panelist: | Yoshio Oyanagi (Kogakuin Univ.) | Invited Talk: | OA-1: "Large-scale gene network analysis and its application" Hideo Matsuda(Osaka Univ., President of JSBi) |
| Satoru Miyano (The Institute of Medical Science, The University of Tokyo) | Oral Presentation: | OA-2: Hiroshi Ishikita (Kyoto
Univ. /JST) OA-3: Yoshitake Sakae(Nagoya Univ.) OA-4: Daisuke Tominaga(CBRC, AIST) OA-5: Motooki Ashihara(Chugai Pharmaceutical Co., Ltd.) OA-6: Masatoshi Tsukahara(TTC, OCGP) OA-7: Hiroyuki Wakaguri (The University of Tokyo) OA-8: Riu Yamashita (The University of Tokyo) Discussion |
|
| Kimito Funatsu (The University of Tokyo) | |||
| Yuji Sugita (RIKEN) | |||
| Masaki Tomimoto (Takeda Pharmaceutical Co. Ltd.) | |||
16:00-18:00 «S1:Special Lecture» |
|||
| 16:00-17:00 | S1-1: 量子ドット Kenji Yamamoto (National Center for Global Health and Medicine) |
||
| 17:00-18:00 | S1-2: 量子情報・量子計算 Kae Nemoto (National Institute of Informatics) |
||
| 18:00-19:00 «Poster Session» (odds#, at Conference Room - 2nd floor) | |||
| September 16 (2nd day) | |||
| Main Hall (Hitotsubasi Memorial Hall:2F) | Sub Hall (Conference Room1:2F) | ||
| 9:15-11:45 «M2:Mini-Symposium» "The Impacts of Next Generation Sequencer" Chair: Hiroshi Tanaka (Tokyo Medical and Dental Univ.) |
9:30-12:00 «OB:Oral Session B» "Computational Drug Discovery" Chair: Noriaki Hirayama (Tokai Univ.) |
||
| 9:15-9:55 | M2-1: "Current Status and Prospect of Genome-Wide Association Study" Katsushi Tokunaga (The Univ. of Tokyo) |
Oral Presentation: | OB-1: Tomoyoshi Seto(Shiga Univ.) OB-2: Takao Matsuzaki(Independent Drug Design Advisor) OB-3: Atsushi Matsuo(Chugai Pharmaceutical) OB-4: Takashi Shindo(Okayama Univ.) OB-5: Junya Yamagishi(Chiba Univ.) OB-6: Richard Cramer III(TRIPOS, L.P.) OB-7: Takashi Imai(RIKEN) OB-8: Shinji Soga(Astellas Pharma) OB-9:Naoyuki Asakawa(Ryoka Systems) |
| 9:55-10:35 | M2-2: "Genomics of human gut microbiota" Masahira Hattori (The Univ. of Tokyo) |
||
| 10:35-11:15 | M2-3: "Prospects for the DNA sequencing revolution" Yoshihide Hayashizaki (RIKEN) |
||
| 11:15-11:45 | Panel Discussion | ||
| ― | 12:15-13:15 «L:Luncheon Seminor 2» World Fusion Co.,LTD. |
||
| 13:30-16:00 «M3:Mini-Symposium» "Hunting Natural Products in the Post-genomic Era" Chair: Masanori Arita (The University of Tokyo) |
13:30-16:00 «OC:Oral Session C» "Chemoinformatics" Chair: Kimito Funatsu (The University of Tokyo) |
||
| 13:30-14:15 | M3-1: "Genetic modification approach for effectively one-pot fermentation
of the novel antitumor macrolide, pladienolide derivatives" Kazuhiro Machida (Mercian Corporation) |
Invited Talk: | OC-1: "Systems-based Drug Discovery" Yasushi Okuno (Kyoto Univ.) |
| 14:15-15:00 | M3-2: "Genomic and metabolomic comparison of secondary metabolites between
prokaryotic and eukaryotic microorganisms" Yasuhiro Igarashi (Toyama Prefectural Univ.) |
Oral Presentation: | OC-2: Masamoto Arakawa(The University of Tokyo) OC-3: Ryota Koga (X-Ability Co.,Ltd.) OC-4: Fumiaki Aruga(Patcore, Inc.) |
| 15:00-15:45 | M3-3: "Metabolic diversity and its application to combinatorial biosynthesis
in plant" Toshiya Muranaka (Osaka Univ.) |
||
| 15:45-16:00 | Masanori Arita (The University of Tokyo) | ||
| 16:00-18:00 «S2:Special Lecture» "Complex Systems and Life" Chair: Hiroshi Tanaka (Tokyo Medical and Dental Univ.), Yukio Tada (The University of Tokyo) |
|||
| 16:00-17:00 | S2-1: "Nonlinear Dynamics: Toward a Scientific Description of Vivid Nature" Yoshiki Kuramoto (Professor Emeritus of Kyoto Univ.) |
||
| 17:00-18:00 | S2-2: "Brain as a complex system" Tsutomu Nakada (University of Niigata) |
||
| 18:00-19:00 «Poster Session» (even#, at Conference Room - 2nd floor) | |||
| September 17 (3rd day) | |||
| Main Hall (Hitotsubasi Memorial Hall:2F) | Sub Hall (Conference Room1:2F) | ||
| 9:30-12:00 «M4:Mini-Symposium» 「創薬の将来展望」 Chair: Tadashi Horiuchi (Keio Univ.),Takatoshi Kawai (Eisai Co., Ltd.) |
9:30-12:00 «OD:Oral Session D» "Algorithm/mathematical modeling & Simulation" Chair: Masayuki Yamamura (Tokyo Institute of Technology) |
||
| 9:30-10:00 | M4-1: "QSAR/CADD to R&D Management and Licensing" Masafumi Yoshimoto (Pharma BDL LLC) |
Oral Presentation: | OD-1: Hiroshi Ito (Academic
Production, Ochanomizu Univ.) OD-2: Kazunari Kaizu (Keio Univ.) OD-3: Satoshi Sawai (The University of Tokyo) OD-4: Yasunori Aoki (Univ. of Waterloo / NII) |
| 10:00-10:20 | M4-2-1: "Global Pharma Innovator -The Challenge of Daiichi Sankyo-" Kazunori Hirokawa (Daiichi Sankyo Co. Ltd.) |
||
| 10:20-10:40 | M4-2-2: "Transformation from R&D to Product Creation" Kappei Tsukahara (Next Generation Systems Core Function Unit, Eisai Co. Ltd.) |
||
| -Coffee Break- | Invited Talk: | OD-5: “Structure of regulatory networks and dynamics of bio-molecules: Predicting unknown from known” Atsushi Mochizuki (Theor. Biol. Lab. RIKEN Advanced Science Institute) | |
| 10:55-11:15 | M4-2-3: "Challenge for Innovation of Drug Discovery" Masaharu Kanaoka (Dainippon Sumitomo Pharma Co., Ltd.) |
||
| 11:15-11:35 | M4-2-4: "Breakthrough Drug Discovery and Emerging Platform Technologies" Hiroyuki Odaka (Takeda Pharmaceutical Co. Ltd.) |
||
| 11:35-12:00 | Panel Discussion | ||
| 14:00-16:30 «M5:Mini-Symposium» "Academia-Private Partnerships in Drug Discovery and Development: Open Innovation Initiatives" Chair: Takayoshi Okabe (The University of Tokyo), Tomokazu Matsusue (Mochida Pharmaceutical Co.,Ltd.) |
|||
| 14:00-14:40 | M5-1: "Promotion of Industry-Academia-Goverment Collaborations for
Drug Discovery and Development in Japan" Toichi Takenaka (Astellas Pharma Inc.) |
||
| 14:40-15:10 | M5-2: "Pharma-Innovation Discovery Competition Shionogi (FINDS)" Tsuneaki Sakata (Shionogi &Co., Ltd.) |
||
| 15:10-15:40 | M5-3: "Access to Innovation - The Roche Approach to Partnering -" Kaoru Suzuki (Roche) |
||
| 16:00-16:30 | M5-4: "Introduction of RIKEN Program for Drug Discovery and Medical
Technology Platforms" Toshio Goto (RIKEN) |
||
| 16:30-17:10 | M5-5: "Bringing down the firewalls -Pre-competitive models for Pharma R&D informatics" Michael R. Barnes (GlaxoSmithKline Medicines Research Centre) |
||
| «Closing Remarks» | |||